FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, particularly to a nutritional composition containing lipid or fat; a protein source; at least about 5 mg/100 kcal of a long-chain polyunsaturated fatty acid source containing docosahexaenoic acid; and at least about 0.2 mg/100 kcal of a probiotic composition containing a number of oligosaccharides, so that an overall fermentation rate profile of the probiotic composition provides increasing an intestinal beneficent bacteria population for a long period of time, as well as 0.015 to 0.1 ppm (pg/mcg) of TGF-β. In addition, the composition contains at least one probiotic.
EFFECT: invention provides the improved digestibility and can be used for premature infants.
11 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| STAGEWISE BABY FEEDING REGIME FOR PROMOTION OF HEALTHY DEVELOPMENT AND GROWTH | 2011 |
|
RU2575747C2 |
| NUTRITIONAL COMPOSITION PROMOTING NORMAL DEVELOPMENT AND GROWTH | 2009 |
|
RU2501553C2 |
| ENDOGENIC TGF-BETA PRESERVATION METHODS | 2009 |
|
RU2547590C2 |
| COMPOSITION, CONTAINING THERMOLABILE MILK PROTEINS AND METHOD FOR OBTAINING THEREOF | 2011 |
|
RU2575178C2 |
| NUTRITIONAL COMPOSITIONS | 2011 |
|
RU2541396C2 |
| APPLICATION OF POLYDEXTROSE FOR PREPARING MILK MIXTURES FOR CHILDREN ON ARTIFICIAL FEEDING | 2006 |
|
RU2415674C2 |
| SYNBIOTIC MIXTURE | 2009 |
|
RU2495927C2 |
| BETA-1,3'-GALACTOSYLLACTOSE FOR TREATING INTESTINAL BARRIER FUNCTION DISEASES | 2020 |
|
RU2818918C2 |
| APPLICATION OF LACTOFERRIN-CONTAINING NUTRITIONAL COMPOSITIONS FOR STIMULATION OF IMMUNE CELLS | 2011 |
|
RU2575776C2 |
| NUTRITIONAL COMPOSITION CONTAINING 2'FUCOSYLLACTOSE AND 3'GALACTOSYLLACTOSE | 2020 |
|
RU2818570C2 |
